100+
man-years of collective pharmaceutical experience
Manufacturing Medicines Across Six Independent Blocks
- 19 Biosimilars
- 26 Oncology
- 7 Immuno-Suppressants
- 13 Hormones
- 4 Softgels
- 114 General Category & Anti-Infective
Inspired by the Kingdom of Saudi Arabia’s Vision 2030, Keuro Life aims to become one of the most trusted pharmaceutical companies in the Kingdom. Keuro Life is dedicated to localizing research and development (R&D) and drug manufacturing. We will establish a state-of-the-art R&D facility and manufacturing plant in the Kingdom of Saudi Arabia to produce high-quality "Made in Saudi" products for both local and international markets.
PFS and Cartridges
Liquid and Lyo Injectables
Soft Gelatin Capsules
Hard Gelatin Capsules
Tablets
The manufacturing facility spans a total plot area of 27,500 sq meters and a buildup area of 23,500 sq meters. It boasts an impressive annual capacity to produce over 800 million dosages. The facility includes a dedicated containment blocks.
A 1,000 square meter R&D center is planned for the site, commencing in April 2027. This center will facilitate product development and analysis, stability and scaling studies, pharmacodynamics study on new molecules, technology transfer, and pilot-scale batch manufacturing.
In the mean time we have started our Product Development activities with our Joint Venture Partners in India and China, whose facilities are approved by USFDA/EU authorities.
Keuro Life Quality Control (QC)– Testing Laboratory is equipped with cutting-edge instruments and advanced technology to ensure precision, reliability, and compliance with industry standards.
man-years of collective pharmaceutical experience
local employees to be hired
drugs to be manufactured
sq meter manufacturing plant to be setup
Pharmaceutical cleanrooms are designed to provide a controlled environment as specified by approved FDA validation and CGMP practice.The modular cleanroom is optimized to create a sterile manufacturing environment for the pharmaceutical products. Filling rooms are typically ISO5 class 100. Complete sterile environment, self levelled epoxy and PVC flooring & modular panels to maintain hygiene and sanctity of the place.Complete sterile environment, self levelled epoxy and PVC flooring & modular panels to maintain hygiene and sanctity of the place
To prevent any kind of cross contamination and reduce human intervention
100% paperless record for manufacturing, packaging & analytical batch records
Automated packaging Line, with track & trace technology, to identify each and every product along the value chain at any point of time, including the warehouse
Founded Netmeds.com & drove the company’s overall strategy and vision. Scaled Netmeds to India’s No 1 online pharmacy and championed the sale of Netmeds to Reliance Industries. In-depth experience across Pharmaceutical value-chain; Has previously created a pharmacy retail chain and a global marketing, fulfillment, and BPO company.
CEO, MFS (a London-based Specialist Lender); Vast expertise in commercial lending, bridging and structured finance (managed a cumulative loan book of £ 1.74 Bn+) Strong experience of investing in and scaling diverse businesses across industries and geographies.
Co-Promoter of RL Fine Chem, one of the leading niche pharmaceutical API manufacturer in India (Revenue of ~$60 Mn). Co-Founder of MAPE, a leading health tech and pharmaceutical focused investment bank and investment company in India. 30+ years experience in advising clients in healthcare, pharmaceutical, insurance and technology space
With over 30 years of international pharmaceutical experience across the U.S., EU, and GCC markets, Sidharth Baid brings deep expertise in both APIs and finished formulations. He has held leadership roles focused on manufacturing excellence, research and development, business development and regulatory compliance. He also currently serves as Managing Director at Ocean Healthcare Private Limited.
Co-Founder of Keuro Life with over 12 years of experience in contract manufacturing, marketing, and business development. Instrumental in forging strategic partnerships and driving growth. With a proven track record in building and nurturing relationships with key stakeholders, including clients, suppliers, and industry leaders.
Rajiv Gulati is a Strategic Consultant to several PE firms in making judicious investments in the Pharmaceutical sector. Prior to this, he was a part of the senior management in companies such as Ranbaxy Laboratories Limited and Eli Lilly and Company.
wholly owned subsidiary of Glatt Ingenieurtechnik Germany, is engaged in designing, engineering and qualification documentation for the new state of the art Al Kharj facility at KSA. With a focus on delivering comprehensive engineering solutions, GIE specializes in all stages of facility design and implementation, including conceptualization, basic and detailed engineering and ensuring compliance with regulatory standards. With a cumulative strength of ≈3000+ globally, we draw expertise of German Engineering with acclaimed project management skills.
